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ARTICLE
Astrocytes monitor cerebral perfusion and control
systemic circulation to maintain brain blood ﬂow
Nephtali Marina1,2*, Isabel N. Christie1,9, Alla Korsak1,9, Maxim Doronin 1,3, Alexey Brazhe4,
Patrick S. Hosford1, Jack A. Wells5, Shahriar Sheikhbahaei 1, Ibrahim Humoud1, Julian F.R. Paton6,
Mark F. Lythgoe5, Alexey Semyanov3, Sergey Kasparov7,8 & Alexander V. Gourine 1*
Astrocytes provide neurons with essential metabolic and structural support, modulate neu-
ronal circuit activity and may also function as versatile surveyors of brain milieu, tuned to
sense conditions of potential metabolic insufﬁciency. Here we show that astrocytes detect
falling cerebral perfusion pressure and activate CNS autonomic sympathetic control circuits
to increase systemic arterial blood pressure and heart rate with the purpose of maintaining
brain blood ﬂow and oxygen delivery. Studies conducted in experimental animals (laboratory
rats) show that astrocytes respond to acute decreases in brain perfusion with elevations in
intracellular [Ca2+]. Blockade of Ca2+-dependent signaling mechanisms in populations of
astrocytes that reside alongside CNS sympathetic control circuits prevents compensatory
increases in sympathetic nerve activity, heart rate and arterial blood pressure induced by
reductions in cerebral perfusion. These data suggest that astrocytes function as intracranial
baroreceptors and play an important role in homeostatic control of arterial blood pressure
and brain blood ﬂow.
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The high metabolic rate associated with brain informationprocessing requires constant and reliable delivery of nutrientsand oxygen that is ensured by intricate mechanisms con-
trolling cerebral blood ﬂow1–3. Effective operation of these
mechanisms over the lifespan maintains cerebrovascular health and
promotes brain longevity. Their dysfunction may precipitate neu-
ronal damage, contribute to cognitive impairment and the devel-
opment of neurodegenerative disease4,5. Cerebral autoregulation is
believed to be one of these key mechanisms, postulated to maintain
constant brain blood ﬂow in the face of signiﬁcant ﬂuctuations in
systemic arterial blood pressure6. However, the theoretical construct
of cerebral autoregulation was developed in the mid 20th century on
the basis of between‐subject analysis of the relationship between
cerebral blood ﬂow and arterial blood pressure (recorded in several
different patient groups) and remained largely unchallenged. Recent
within-subject studies demonstrated that cerebral autoregulation can
only maintain brain blood ﬂow within a narrow range of changes in
the arterial pressure and that the buffering capacity of cerebral
vasculature against decreases in perfusion pressure is rather low2,7,8.
If so, how does the brain protect itself against hypoperfusion?
Whilst arterial baroreceptors in the carotid bifurcation and the
aortic arch are placed strategically to monitor systemic arterial
blood pressure, they are located “upstream” to the brain and cannot
possibly detect changes in brain perfusion. Moreover, systemic
arterial blood pressure is well maintained in conditions of complete
arterial baroreceptor denervation or chronic baroreceptor unload-
ing9. This points to the existence and necessity of an intrinsic brain
mechanism capable of sensing decreases in cerebral perfusion
pressure (i.e. an intracranial baroreceptor) and transmitting this
information to the CNS neural circuits that control systemic arterial
blood pressure and heart rate forming a homeostatic feedback loop.
Such a sensor has not been convincingly identiﬁed.
This study tested the hypothesis that CNS glial cells called
astrocytes function as physiological sensors of brain blood ﬂow. We
show that astrocytes respond to acute decreases in cerebral perfu-
sion pressure with immediate elevations in intracellular [Ca2+].
Blockade of Ca2+-dependent signaling mechanisms in astrocytes
that populate the CNS regions harboring the autonomic control
circuits prevents compensatory increases in sympathetic nerve
activity, heart rate and arterial blood pressure induced by reductions
in brain perfusion. These data suggest that astrocytes play an
important role in the homeostatic control of global brain
blood ﬂow.
Results
Control of systemic circulation by an intracranial baror-
eceptor. Brain blood ﬂow is driven by cerebral perfusion pressure
(CPP) which is determined by the difference between the mean
arterial blood pressure (MAP) and intracranial pressure (ICP)
(Fig. 1a). If an intracranial baroreceptor exists, then in response to
physiologically-relevant decreases in brain perfusion it should be
able to trigger increases in sympathetic vasomotor and cardiac
activities to raise systemic arterial blood pressure and heart rate.
In studies using adult laboratory rats, we induced acute decreases
in CPP by increasing ICP using a water column connected via a
saline-ﬁlled mini-catheter to the chamber of the lateral cerebral
ventricle (Fig. 1b). Raising ICP by 10–15mmHg, i.e. to the levels
known to occur physiologically, for example in response to acute
postural changes10, reduced cerebral blood ﬂow across the brain
by ~40% (Fig. 1c, d; Supplementary Fig. 1). Reduced brain per-
fusion triggered robust activation of the central cardiovascular
sympathetic drive (Fig. 1h), increased systemic arterial blood
pressure and heart rate (Fig. 1e, f), which collectively facilitated
brain oxygen delivery (Fig. 1e, f). The cardiovascular and sym-
pathetic responses followed ICP increases with a mean delay of
32 ± 7 s (mean ± SEM; Fig. 1g) and outlasted the duration of the
experimental stimulus (5 min of raised ICP) by 37 ± 5 min (mean
± SEM; n= 10). The cardiovascular responses induced by
increases in ICP were abolished in conditions of autonomic
sympathetic blockade (Fig. 1e, f). These data are in agreement
with the recently reported results of the experiments performed in
anaesthetized mice11, conscious sheep12, and humans11.
Astrocytes sense decreases in brain perfusion. All penetrating
and intraparenchymal cerebral blood vessels are wrapped by end-
feet of astrocytes13, numerous multifunctional glial cells that
provide neurons with metabolic and structural support, modulate
neuronal circuit activity and contribute to brain information
processing14–19. Since changes in vascular lumen diameter or
vascular wall deformations associated with changes in ICP and
brain perfusion would be expected to result in mechanical dis-
tortion of tight astroglial endfeet, we hypothesized that astrocytes
would be ideally positioned to function as brain baroreceptors.
Using 2-photon imaging in vivo we recorded robust [Ca2+]i
responses of rat cortical astrocytes to increases in ICP (Fig. 2). Cell
bodies, large processes and endfeet of astrocytes were identiﬁed by
SR101 dye labeling (Fig. 2b). From a total of 133 regions of interest
(ROIs) corresponding to astroglial somas, 259 ROIs corresponding
to major astroglial processes and 112 ROIs corresponding to
endfeet (504 ROIs in total) recorded in 7 animals, 408 (81%) ROIs
responded to decreases in brain perfusion with increases in
the frequency and duration of [Ca2+]i signals (Fig. 2c, d). No
signiﬁcant increases in the number of [Ca2+]i signals were induced
by raised ICP in 38 cortical cells that lacked SR101 labeling
(putative neurons) (Fig. 2e; Supplementary Fig. 2). Increases in ICP
were associated with increases in lumen diameter of penetrating
cortical arterioles (by 12 ± 3%; mean ± SEM; 16 vessels recorded in
6 animals) (Fig. 2c, d). Dilations of cortical vessels occurred when
ICP was reaching the peak levels applied in these experiments (>10
mmHg) and were always preceded by [Ca2+]i responses in
neighboring astrocytes (Fig. 2c, d). The prevalent response of
cortical astrocytes to raised ICP in vivo manifested as increased
active time (% of time when [Ca2+]i was elevated) and frequency of
[Ca2+]i signals in somas, major processes and endfeet (Fig. 2c–e).
Peak increases in frequency of [Ca2+]i signals in all the
compartments of cortical astrocytes were observed at both ICP
stimulus onset and offset (Fig. 2c, d). Increased frequency of
astroglial [Ca2+]i signals were maintained after the cessation of the
ICP challenge (Fig. 2c), concomitantly with the lasting cardiovas-
cular response, which continued beyond the duration of the
stimulus (Fig. 1e, f; Supplementary Fig. 3).
Responses of the brainstem astrocytes. Arterial blood pressure is
determined by autonomic sympathetic activity that controls the
rate and strength of cardiac contractions as well as the diameter
of peripheral resistance arterioles20. Sympathetic cardiovascular
tone is controlled predominantly by the bilaterally organized
groups of neurons located in the ventrolateral brainstem20,21
(Fig. 3a). These neurons send monosynaptic excitatory projec-
tions to spinal sympathetic preganglionic neurons and are sen-
sitive to astroglial signaling molecules22. We next tested the
hypothesis that sympathetic and cardiovascular responses to
decreases in brain blood ﬂow are triggered by brainstem astro-
cytes that sense changes in perfusion pressure and activate CNS
sympathetic control circuits via Ca2+-dependent release of a
prototypical gliotransmitter ATP14.
Using a surgical approach to the ventral surface of the
brainstem19,23 and confocal microprobe imaging (Fig. 3b) we
next determined whether astrocytes that reside in close proximity
to the brainstem sympathetic control circuits are similar to
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Fig. 1 Control of systemic circulation by an intracranial baroreceptor. a Brain blood ﬂow is driven by cerebral perfusion pressure (CPP) which is
determined by the difference between the mean arterial blood pressure (MAP) and intracranial pressure (ICP). CVP, central venous pressure. b Diagram of
the experimental setup in anesthetized rats instrumented for the recordings of cortical tissue partial pressure of oxygen (PtO2), ICP (via a cannula
implanted into the 3rd cerebral ventricle, 3V), systemic arterial blood pressure and renal sympathetic nerve activity (RSNA). CPP was acutely decreased by
raising ICP using a water column connected via a saline-ﬁlled mini-catheter to a cannula placed in the lateral cerebral ventricle (LV). c High resolution
magnetic resonance scan of the rat brain with regions of interest outlined and d summary data illustrating values of cerebral blood ﬂow (CBF) at resting
conditions and in conditions when ICP was raised by 10–15 mmHg. Individual values and means ± SEM are shown. p-values, Wilcoxon signed-rank test.
e Representative raw traces and f summary data (means ± SEM) illustrating changes in cortical PtO2, CPP (calculated), ICP, heart rate (HR) and arterial
blood pressure (ABP) induced by an experimental manoeuvre to increase ICP by ~10mmHg in control conditions and under systemic ganglionic blockade
with chlorisondamine. p-values, ANOVA. g Representative recording (expanded) illustrating a short delay between the onset of ICP increase and the
resultant blood pressure response. h Representative recordings of RSNA and ABP responses to graded increases in ICP. Source data are provided as a
Source Data ﬁle.
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cortical astrocytes and respond to changes in brain perfusion with
elevations in [Ca2+]i. It was found that increases in ICP trigger
robust [Ca2+]i responses in cells that populate the most-ventral
regions of the brainstem (Fig. 3c–e). Microprobe focal depth of
<75 µm restricted Ca2+ imaging to the marginal layer that in this
part of the brainstem contains a dense network of astroglial
processes and cell bodies and only sparse neurons and neuronal
ﬁbers (Fig. 3b). Thus, although OGB was used as a Ca2+ indicator
in these experiments, recorded changes in ﬂuorescence (Fig. 3c–e)
are most likely representing the bulk responses of ventral
brainstem astrocytes to decreases in brain perfusion. While
signals from individual cells cannot be resolved in the imaging
experiments of this type, averaging changes in OGB ﬂuorescence
induced by increases in ICP across all the animals (n= 8)
demonstrated responses that were sustained during the period of
raised ICP (Fig. 3e).
Astrocytes mediate cardiovascular responses to decreases in
brain perfusion. Next, we disrupted signaling between astrocytes
and sympathoexcitatory neurons by virally driven expression of
either the light chain of tetanus toxin (TeLC), the dominant-
negative SNARE (dnSNARE) protein, or a potent ATP-degrading
enzyme transmembrane prostatic acid phosphatase (TMPAP) in
astrocytes of the ventrolateral brainstem of adult rats (Fig. 4).
Both TeLC and dnSNARE effectively block Ca2+-dependent
vesicular exocytosis in astrocytes and prevent the propagation of
mechanosensory Ca2+ excitation between astrocytes17,24.
TMPAP expression prevents ATP accumulation in astroglial
vesicular compartments and blocks ATP-mediated signaling25,26.
In rats expressing the control transgene (CatCh-EGFP) in the
brainstem astrocytes, raised ICP triggered increases in MAP by
21 ± 4 mmHg (mean ± SEM; ANOVA; p= 0.003; n= 6), heart
rate by 49 ± 11 bpm (mean ± SEM; ANOVA; p= 0.006; n= 6),
and renal sympathetic nerve activity by 39 ± 9% (mean ± SEM;
ANOVA; p= 0.006; n= 6) (Fig. 4c, d). These responses were
similar to the responses induced by the increased ICP stimulus in
the naive animals (Fig. 1e, f). When brainstem astrocytes were
transduced to express either TeLC, dnSNARE or TMPAP,
increases in ICP had no effect on MAP, heart rate and
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Fig. 2 Astrocytes sense decreases in brain perfusion. a Diagram of the experimental setup in anesthetized rats instrumented for the recordings of
intracranial pressure (ICP), systemic arterial blood pressure (ABP) and two-photon imaging of [Ca2+]i in cortical astrocytes using a Ca2+-sensitive dye
Oregon Green BAPTA 1 AM (OGB). b Representative images illustrating the identiﬁcation of cortical astrocytes using sulforhodamine 101 (SR101) labeling
and levels of OGB ﬂuorescence at baseline (ICP= 2 mmHg) and in conditions of raised ICP (ICP= 18 mmHg). Regions of interest (ROIs) corresponding to
astroglial somas, major parenchymal processes and perivascular endfeet detected by automated software are highlighted. One SR101-negative cell (n1) was
identiﬁed in this ﬁeld of view. Scale bar: 100 μm. c Representative traces derived from the recording illustrated in (b) showing [Ca2+]i responses of
individual cell bodies, major processes and endfeet of cortical astrocytes as well as changes in the diameter of penetrating arterioles induced by changes in
ICP. Arrows point to the onset of vascular responses. d Averages (means ± SEM) of [Ca2+]i signals in cell bodies, processes and endfeet of cortical
astrocytes and changes in the diameter of penetrating arterioles (16 vessels) plotted in relation to the averaged trace of ICP changes recorded in 6 animals
and focusing on time periods around the raised ICP stimulus onset and offset. e Summary data illustrating the effect of raised ICP on Ca2+ active time
(% of time when [Ca2+]i is elevated) recorded in somas, major processes and endfeet of cortical astrocytes as well as the frequency of [Ca2+]i signals in
astrocytes and neurons. The data are shown as individual values and means ± SEM. p-values, paired t-test. Source data are provided as a Source Data ﬁle.
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sympathetic nerve activity (Fig. 4c, d; Supplementary Fig. 4).
Expression of TeLC or dnSNARE in brainstem astrocytes had no
effect on resting levels of blood pressure and heart rate (recorded
for 24 h) in conscious rats during normal behavior (Supplemen-
tary Table 1). These data provide evidence against a potential
non-speciﬁc depressant effect of compromised vesicular release
mechanisms in the brainstem astrocytes on the operation of the
cardiovascular control circuits.
Thus, compensatory sympathetic and cardiovascular responses
to decreases in brain perfusion are equally abolished by either
pharmacological autonomic blockade (Fig. 1e, f) or speciﬁc
disruption of brainstem astroglial signaling mechanisms (Fig. 4c,
d), indicating that these responses are initiated and maintained by
astrocytes juxtaposed to the CNS sympathetic control circuits.
Discussion
Baroreceptors located in the carotid bifurcation and the aortic
arch are important for the operation of the arterial baroreﬂex,
preventing potentially brain-damaging large ﬂuctuations of the
systemic arterial blood pressure. However, peripheral arterial
baroreceptors are unable to sense decreases in brain perfusion.
With recent data indicating that cerebral autoregulation only
operates over a narrow range of the arterial blood pressure
changes2, the brain would seemingly be vulnerable to hypo-
perfusion under certain conditions. This study identiﬁes astro-
cytes as physiological sensors of brain perfusion that appear to
play an important role in the homeostatic control of cerebral and
systemic circulation. These numerous brain cells sense decreases
in cerebral perfusion pressure and, at the level of the brainstem,
activate sympathetic control circuits to increase the arterial blood
pressure and heart rate in order to maintain brain blood ﬂow and
preserve brain oxygen delivery. At a local level, mechanosensory
Ca2+ responses in astroglial end-feet may play a role in ﬂow- or
pressure-dependent control of the associated microvasculature
(arterioles and capillaries) via Ca2+-dependent release of
vasoactive signaling molecules1. Indeed, Ca2+ responses evoked
by ICP increases in cortical astrocytes precede dilations of
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Fig. 3 Responses of brainstem astrocytes to decreases in brain perfusion. a Schematic drawings of the rat brain in parasagittal and coronal projections
illustrating the anatomical location of the sympathetic control circuits in the ventrolateral medulla oblongata (VLM) of the brainstem sending excitatory
projections to sympathetic preganglionic neurons of the intermediolateral (IML) spinal cord. Astrocytes that reside within and in close proximity to the
brainstem sympathetic control circuits of the VLM are hypothesized to function as intracranial baroreceptors. b Diagram of the experimental setup in
anesthetized rats instrumented for the recordings of intracranial pressure (ICP), systemic arterial blood pressure (ABP) and confocal microprobe imaging
of changes in Oregon Green BAPTA 1 AM (OGB) ﬂuorescence in the most-ventral regions of the VLM. Inset: a representative image showing that in this
part of the brainstem the marginal layer contains a dense network of astroglial processes and cell bodies (identiﬁed by GFAP immunoreactivity) and only
sparse neurons and neuronal ﬁbers (identiﬁed by MAP2 immunoreactivity; arrows point to the neuronal cell bodies that are closest to the ventral surface of
the brainstem). Scale bar: 100 μm. c Representative images showing changes in OGB ﬂuorescence recorded in the most ventral aspect of the VLM in
response to raised ICP. Images were taken at the times indicated by arrows on panel (d). Scale bar: 50 μm. d Traces illustrating changes in OGB
ﬂuorescence in the regions of interest (ROI) outlined on (c) showing widespread [Ca2+]i responses evoked by ICP increase. e Averages (means ± SEM) of
changes in [Ca2+]i recorded in the ventral brainstem and plotted in relation to the averaged traces of ICP and mean arterial blood pressure (MAP)
responses recorded in 8 animals. Source data are provided as a Source Data ﬁle.
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penetrating arterioles, however, establishing the causality and the
functional signiﬁcance of these responses is beyond the scope of
this study.
In physiology, baroreceptor is a sensor that reacts to changes in
pressure. The data obtained in this study demonstrate that
astrocytes respond to changes in intracranial/cerebral perfusion
pressure and, therefore, these brain cells can be potentially classed
as baroreceptors. Astroglial responsiveness to mechanical stimuli,
a well-recognized, yet functionally underappreciated, feature of
these brain cells is hypothesized to be central for the operation of
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the identiﬁed mechanism. Two peaks of Ca2+ responses in cor-
tical astrocytes that occur at the ICP stimulus onset and offset
show a striking resemblance to the response proﬁles of certain
subsets of peripheral mechanosensory neurons27,28, although
astroglial and neuronal responses to mechanical stimuli develop
over the different timescales.
The results of this study add to the growing body of evidence
suggesting that astrocytes function as versatile surveyors of CNS
metabolic milieu29, capable of detecting changes in the brain
parenchymal levels of metabolic substrates (oxygen)24, and
metabolic waste products (CO2, H+)19,23,30,31. Distinct stimuli
that could indicate conditions of potential metabolic threat, such
as hypoxia24, hypercapnia19, and hypoperfusion (this study), all
trigger somewhat stereotypical Ca2+ responses in astrocytes.
Astroglial populations that are intermingled with the respiratory
and cardiovascular control neuronal networks are well positioned
to orchestrate adaptive changes in breathing, heart rate and
arterial blood pressure in conditions of increased metabolic
demand. Failure of these mechanisms may augment metabolic
deﬁcit, precipitate neuronal damage, contribute to the develop-
ment of neurological and neurodegenerative disease and reduce
brain longevity.
Methods
All animal experimentations were performed in accordance with the European
Commission Directive 86/609/EEC (European Convention for the Protection of
Vertebrate Animals used for Experimental and Other Scientiﬁc Purposes) and the
UK Home Ofﬁce (Scientiﬁc Procedures) Act (1986) with project approval from the
University College London Institutional Animal Care and Use Committee. The rats
were group-housed and maintained on a 12-h light cycle (lights on 07:00) and had
ad libitum access to water and food.
Experimental animal models and measurements. Young adult Sprague-Dawley
rats (250–300 g) were anesthetized with urethane (induction: 1.3 g kg−1, i.p.;
maintenance: 10–25 mg kg−1 h−1, i.v.). Adequate anesthesia was ensured by
maintaining stable levels of the arterial blood pressure (ABP) and heart rate
showing lack of responses to a paw pinch. The femoral artery and vein were
cannulated for measurements of ABP and administration of anesthetic, respec-
tively. The trachea was cannulated, and the animal was mechanically ventilated
with air supplemented with oxygen using a positive pressure ventilator with a tidal
volume of ∼1 ml per 100 g of body weight and ventilator frequency similar to the
resting respiratory rate (∼60 strokes min−1). The third cerebral ventricle was
cannulated and connected via a saline-ﬁlled mini-catheter to a pressure transducer
to record changes in intracranial pressure (ICP) (Fig. 1b). Correct positioning of
the cannula was conﬁrmed by observing cardiac pulse-related small oscillations in
ICP. The lateral cerebral ventricle was cannulated and connected via a saline-ﬁlled
mini-catheter to a water column for the delivery of the experimental stimulus
(Fig. 1b). End-tidal level of CO2 was monitored continuously (Capstar-100,
CWE). PO2, PCO2, and pH of the arterial blood were measured regularly and
kept within the physiological ranges (PO2 95–105 mmHg; PCO2 35–45 mmHg
and pH 7.35–7.45) by adjusting the tidal volume and/or ventilator frequency as
well as the level of supplemental oxygen. The body temperature was maintained
at 37.0 ± 0.5 °C.
The left renal nerve was dissected retroperitoneally and placed on bipolar silver
electrodes to record renal sympathetic (vasomotor) nerve activity (RSNA). RSNA
was ampliﬁed (× 20,000), ﬁltered (80–1000 Hz), and sampled at a rate of 11 kHz.
Rectiﬁed RSNA was then smoothed with a time constant of 100 ms to obtain the
mean level of activity. Changes in RSNA recorded during the experiment were
normalized with respect to resting activity (100%) and complete absence of
sympathetic discharges (0%) following administration of the ganglionic blocker
hexamethonium (20 mg; i.v.) at the end of the experiment.
Partial pressure of tissue O2 (PtO2) in the somatosensory region of the cortex
was recorded using optical probes (250 μm tip diameter; OxyLite system; Oxford
Optronix) placed 1–2 mm below the cortical surface. The operation of the sensor is
based on optical ﬂuorescence technology that allows real-time recording of
absolute changes in tissue PO2.
Changes in cerebral blood ﬂow (CBF) in response to the increased ICP were
recorded in urethane-anesthetized rats using arterial spin labeling (ASL) magnetic
resonance imaging (MRI)26,32. In these experiments, cisterna magna was
cannulated (Supplementary Fig. 1) and connected via saline-ﬁlled mini-catheter to
a Hamilton syringe for the delivery of the experimental stimulus (raised ICP). The
animal’s head was secured within the MRI scanner with ear and incisor bars.
Imaging was performed using a 9.4T horizontal bore scanner (Agilent) with a
72 mm inner diameter volume coil for transmission (Rapid Biomedical) and a 4-
channel array head coil (Rapid Biomedical) for signal acquisition. A ﬂow sensitive
alternating inversion recovery (FAIR) ASL MRI sequence with a three shot
segmented EPI readout was applied to measure the CBF. The following sequence
parameters were used: TR= 5000 ms, TI= 2000 ms, matrix size= 64 × 64, FOV=
35 mm × 35 mm, TE= 10 ms, single slice (slice thickness= 2 mm), inversion pulse
bandwidth= 20 kHz. FAIR images were acquired every 30 s. Time-series data were
extracted from manually drawn ROIs in the cortex and the striatum (Fig. 1c,
Supplementary Fig. 1). CBF was quantiﬁed from the ASL data33.
Biotelemetry was used to record 24 h systemic ABP and heart rate in conscious
freely-behaving animals34. Rats (220–250 g) were anesthetized with isoﬂurane
(2–4% in O2-enriched air) and a laparotomy was performed to expose the
abdominal aorta. A catheter connected to a telemetry pressure transducer (model
TA11PA-C40, Data Science International) was advanced centrally into the aorta
and secured with Vetbond (3M). The incision was closed by suturing. The animals
received buprenorphine (0.05 mg−1 kg−1 per day, subcutaneous) for 3 days and
were allowed to recover for 7 days in their home cages.
Viral gene transfer. Rats (200–250 g) were anesthetized with a mixture of keta-
mine (60 mg kg−1, i.m.) and medetomidine (250 μg kg−1, i.m.) and placed in a
stereotaxic frame. Regions of the ventrolateral medulla oblongata harboring sym-
pathoexcitatory neural circuits (Fig. 3a) were targeted bilaterally by advancing a
glass micropipette from the dorsal surface of the cerebellum following a small
craniotomy. Viral vectors were delivered via two microinjections (1 μl each, 0.1 μl
min−1) per side using the following coordinates from Bregma: 12 and 12.5 mm
caudal, 2 mm lateral, and 8 mm ventral. After the microinjections, the wound was
sutured and anesthesia was reversed with atipamezole (1 mg kg−1, i.m.). For
postoperative analgesia, the animals received buprenorphine (0.05 mg−1 kg−1
per day, subcutaneous) for 3 days. No complications were observed after the
surgery and the animals gained weight normally. The animals were left to recover
for 7–10 d before the experiments to ensure stable and high level of transgene
expression.
Molecular approaches to block astroglial signaling. Signaling between the
brainstem astrocytes and between the brainstem astrocytes and sympathoexcitatory
neurons was disrupted by virally driven expression of either the light chain of
tetanus toxin (TeLC), the dominant-negative SNARE (dnSNARE) protein, or
potent ATP-degrading enzyme transmembrane prostatic acid phosphatase
(TMPAP). TeLC expression facilitates proteolytic degradation of SNARE pro-
teins35 that mediate vesicular docking and fusion. dnSNARE protein locks vesicles
in the transient fusion stage, preventing the pore from widening to the full-fusion
state36. Both TeLC and dnSNARE effectively block Ca2+-dependent vesicular
release mechanisms in astrocytes and prevent the propagation of mechanosensory
Ca2+ excitation between astrocytes17,24. Generation of the adenoviral vectors
(AVV) for the expression of TeLC (AVV-sGFAP-EGFP-skip-TeLC; titer: 2 × 1010)
and dnSNARE (AVV-sGFAP-dnSNARE-EGFP; titer 3 × 1010) under the control of
the enhanced GFAP promoter and validation of the transgenes efﬁcacy in blocking
vesicular release and signaling between astrocytes were described in detail
previously17,24.
To block ATP-mediated signaling by promoting rapid breakdown of
extracellular ATP and downstream purines, the sympathetic control regions of the
brainstem were targeted with a lentiviral vector (LVV) to express TMPAP37.
Expression of TMPAP was driven under the control of an elongation factor 1α
(EF1α) promoter (LVV-Ef1α-TMPAP-EGFP). TMPAP expression prevents ATP
accumulation in astroglial vesicular compartments, blocks ATP-mediated signaling
and effectively limits the propagation of mechanosensory Ca2+ waves between
astrocytes25,26. In the control animals, brainstem astrocytes were targeted to
express enhanced green ﬂuorescent protein (EGFP or CatCh-EGFP) using adeno-
or lentiviral vectors.
Experimental protocols.
1. In naive rats the CBF was measured using ASL MRI. The experimental setup
was ﬁrst pre-calibrated outside of the MRI scanner to deliver increases in
ICP by 10–15 mmHg for 30–60 s. During imaging, the experimental
stimulus of this duration was applied for the purpose of measuring acute
CBF changes to ICP increases that occur prior to the full development of the
compensatory systemic cardiovascular response (Supplementary Fig. 1).
2. In naive rats acute decreases in cerebral perfusion pressure were induced by
increasing ICP using a water column connected via saline-ﬁlled mini-
catheter to the chamber of the lateral cerebral ventricle. ICP was
manipulated by changing the vertical position of the column relative to
the surface of the brain. Cortical PtO2, RSNA, heart rate and ABP responses
evoked by increases in ICP to the levels known to occur physiologically (by
10–15 mmHg)10, were recorded in control conditions and under systemic
ganglionic blockade (induction: chlorisondamine 1 mg kg−1, i.v. bolus;
maintenance: hexamethonium 15mg kg−1 h−1, i.v. infusion). In animals
receiving systemic ganglionic blockade, ABP was restored and maintained at
a physiological level by intravenous infusion of vasopressin (0.15 nm; 10 μl
min−1).
3. In animals transduced to express TeLC, dnSNARE, TMPAP or control
transgene in the brainstem astrocytes, decreases in cerebral perfusion
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pressure were induced by raising ICP using the water column as described
above. Changes in cortical PtO2, RSNA, heart rate and ABP evoked by
increases in ICP were recorded.
4. In conscious freely-moving rats the ABP was recorded continuously for 24 h
on day 8 after the microinjections of viral vectors to express TeLC,
dnSNARE or control transgene (EGFP) in astrocytes of the ventrolateral
brainstem. Heart rate data were derived from the blood pressure recordings.
Two-photon imaging. Young rats (100–150 g) were anesthetized with urethane (1
g kg−1, i.v.) and α-chloralose (50 mg kg−1, i.v.). Adequate anesthesia was ensured
by maintaining stable levels of ABP and heart rate showing lack of responses to a
paw pinch. The femoral artery and vein were cannulated for measurements of ABP
and administration of anesthetic, respectively. The trachea was cannulated, and the
animal was mechanically ventilated using a positive pressure ventilator with a tidal
volume of ∼1 ml per 100 g of body weight and a ventilator frequency similar to the
resting respiratory rate (∼60 strokes min−1). The animal was then placed in a
stereotaxic frame. The skin overlying the skull was removed, and a small cra-
niotomy (∼3 mm2) was made in the parietal bone above the somatosensory cortex.
Cortical astrocytes were labeled with sulforhodamine 101 (SR101) and loaded with
a Ca2+-sensitive dye Oregon Green BAPTA 1 AM (OGB). OGB was dissolved
initially in DMSO and 20% Pluronic F127. The solution containing OGB (1 mM)
and SR101 (8 μM) in artiﬁcial cerebrospinal ﬂuid (aCSF; 124 mM NaCl, 3 mM
KCl, 2 mM CaCl2, 26 mM NaHCO3, 1.25 mM NaH2PO4, 1 mM MgSO4, 10 mM
D-glucose saturated with 95% O2/5% CO2, pH 7.4) was delivered via a glass
micropipette at four to six sites within the targeted area of the cortex. The exposed
surface of the brain was then covered with agarose and protected with a glass
coverslip secured to the skull using acrylic dental cement. The third cerebral
ventricle was cannulated and connected via saline-ﬁlled mini-catheter to a pressure
transducer to record changes in ICP (Fig. 2a). The lateral cerebral ventricle was
cannulated and connected via saline-ﬁlled mini-catheter to a water column for the
delivery of the experimental stimulus (Fig. 2a). During imaging the animal was
paralyzed with gallamine triethiodide (induction: 50 mg kg−1, i.v.; maintenance:
10 mg kg−1 h−1, i.v.). Arterial PO2, PCO2, and pH were measured regularly and
kept within the physiological ranges by adjusting tidal volume and/or ventilator
frequency. The body temperature was maintained at 37.0 ± 0.5 °C.
Cellular [Ca2+]i responses in the cortex were recorded using an Olympus
FV1000 microscope (Olympus), equipped with MaiTai HP DeepSee laser (Spectra-
Physics). A 25x water-immersion objective (XLPlan N, NA 1.05; Olympus) was
used. Fluorophores were excited in two-photon XYZ-t mode at 800 nm. Red
ﬂuorescence (SR101) was separated from green ﬂuorescence (OGB) using a
dichroic mirror. Images were acquired up to 200 μm deep from the cortical surface.
Z-stacks (~15 μm) were acquired to enable tracking of cells that moved in the z-
plane during the experimental period. For time-lapse imaging, stacks of 15 μm (ﬁve
focal planes) were acquired at 320 × 320 pixel resolution. The laser power was kept
to a minimum to reduce phototoxicity (average power 12 mW). Time-lapse series
were recorded for up to 20 min.
Analysis of two-photon imaging data. Lateral motion in the imaging data was
corrected sequentially ﬁrst for rigid-body shifts of the ﬁeld of view and then by the
combined local-global (CLG) optical ﬂow estimation algorithm using SR101
channel for movement ﬁelds estimation. Python implementation of the CLG from
image-funcut software was used (https://github.com/abrazhe/image-funcut/tree/
develop).
Time-varying baseline ﬂuorescence proﬁle F0(t) was estimated in a two-stage
process. First, low-rank slow trends were estimated by projecting ﬂuorescence data
onto a truncated singular value decomposition F=UΣV*, where F is a (Nf × Npx)
matrix where each row is a frame unraveled into a row vector, Npx is the total
number of pixels in each frame and Nf is the number of frames. In this
decomposition columns of the unitary matrix V are spatial principal components
and columns of the unitary matrix U are the corresponding temporal signals, while
elements of the diagonal matrix Σ deﬁne power stored in each component. We
applied iteratively reweighted least-squares smoothing to the temporal signals to
remove short transient upswings and performed a truncated projection back into
the image space by using only the ﬁrst r= 20 columns of U and V. Next, using
μCats Python software (https://doi.org/10.5281/zenodo.1242164; https://github.
com/abrazhe/uCats), small local deviations from the slow low-rank dynamics were
corrected by temporal smoothing of spatially averaged data in small overlapping
windows. Validity of baseline ﬂuorescence estimation was conﬁrmed by visual
inspection.
Raw ﬂuorescence data can be very noisy if analyzed pixel-by-pixel, whereas
spatial binning reduces resolution. Therefore, a combined selective averaging and
transient detection was next performed. In a moving window, all ΔF/F0 signals
were projected onto ﬁrst few principal components and then clustered. A cluster
containing the signal from the center of the window was selected, and all temporal
signals from the pixels belonging to this cluster were averaged. The standard
deviation of noise in the averaged signal was estimated, and a temporally smoothed
signal was thresholded at two standard deviations of the noise. This provided a
local estimate of ﬂuorescence transients, which was accumulated in all pixels
belonging to the same cluster with the central pixel of the window, with a weight
reversely proportional to the distance in the cluster space. Thus, most pixels
received multiple estimates of denoised ﬂuorescence dynamics, because each pixel
could belong to different clusters within different windows. These estimates were
then aggregated according to the recorded weights. This approach was tested on
synthetic data and produced excellent results even at low signal to noise ratios and
overlapping spatial components (μCats software).
To analyze [Ca2+]i signals originating from astroglial cell bodies (somas), large
parenchymal processes and perivascular endfeet, an automated ROI selection
procedure was applied. Bright regions in SR101-labeled frames were segmented
using adaptive thresholding in 11 × 11 pixel blocks in each frame and then
contiguous regions which were taken as foreground in more than 50% of frames
were identiﬁed. These regions were used as ROI masks to extract denoised ΔF/F0
traces (Fig. 2b, c).
Confocal microprobe imaging. Rats (250–300 g) were anesthetized with urethane
(induction: 1.3 g kg−1, i.p.; maintenance: 10–25 mg kg−1 h−1, i.v.), mechanically
ventilated and instrumented for the recording of ABP, ICP and delivery of the
raised ICP stimulus using a water column, as described above (Fig. 3b). The animal
was then placed in a supine position with the head secured in a stereotaxic frame.
The ventral surface of the brainstem was exposed via a small craniotomy (diameter
1 mm) at the basilar part of the occipital bone23,38. For Ca2+ imaging, the OGB
solution (1 mM) was delivered via a glass micropipette by a single microinjection
into the ventral aspect of the lateral medulla oblongata harboring sympathetic
control circuits. [Ca2+]i responses induced by ICP increases were recorded using a
confocal laser (488 nm) microprobe (focal depth ~75 µm; Cellvizio, Mauna Kea
Technologies). The microprobe was placed just above the brainstem surface and
secured in place with silicone to ensure a hermetic seal. For time-lapsed recordings,
images of ﬂuorescence were acquired every 3 s and the laser power was kept to a
minimum to reduce phototoxicity.
Histology and immunohistochemistry. At the end of the experiments, the rats
were given an anesthetic overdose (urethane, 1.5 g kg−1, i.p.) and perfused trans-
cardially with 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4). The
brains were removed and post-ﬁxed in the same solution for 24 h at 4 °C. After
cryoprotection in 30% sucrose, serial transverse sections (30 μm) of the medulla
oblongata were cut. Free-ﬂoating tissue sections were incubated overnight at 4 °C
with either chicken anti-green ﬂuorescent protein (GFP) (1:500; Cat#: GFP-1010,
Aves Labs) and rabbit anti-tyrosine hydroxylase (TH) antibody (1:500; Cat#: sc-
14007, Santa Cruz) or with rabbit anti-glial ﬁbrillary acidic protein (GFAP) (1:500;
Cat#: Z0334, Dako) and mouse anti-microtubule-associated protein 2 (MAP2)
antibody (1:500; Cat#: M9942, Sigma). The sections were subsequently incubated in
speciﬁc secondary antibodies conjugated to the ﬂuorescent probes (each 1:1000;
Life Science Technologies) for 1 h at room temperature. Images were obtained
using a confocal microscope (Leica).
Statistical analysis. Physiological data were acquired using Power1401 interface
and analyzed ofﬂine using Spike2 software (Cambridge Electronic Design). Cellular
[Ca2+]i responses, changes in PtO2, MAP, CPP, HR, and RSNA induced by
increases in ICP in the absence and presence of test drugs/treatments or expression
of a particular transgene in the brainstem astrocytes were compared by Student’s t-
test, Wilcoxon signed-rank test, or analysis of variance (ANOVA) (NCSS 2007), as
appropriate. The data are shown as individual values and/or means ± SEM. Dif-
ferences with p < 0.05 were considered to be signiﬁcant.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The data that support the ﬁndings of this study are available from the corresponding
authors upon request. The source data underlying Figs. 1d, f, 2d, e, 3e, 4d, Supplementary
Figs. 1, 4, 5 and Supplementary Table 1 are provided as a Source Data ﬁle.
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